Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.475 -0.615 (-7.60%)
Streaming Delayed Price Updated: 10:28 AM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
5 Top Stocks Cathie Wood Bought This Week
Cathie Wood is still buying the dip and believes that deflationary forces may soon show out. Here are five top stocks she bought this week. 
Via InvestorPlace
Cathie Wood Just Doubled Down on Ginkgo Bioworks (DNA) Stock
While Ginkgo Bioworks may be a relatively unknown name to many investors, DNA stock is quite well known to Cathie Wood and her Ark funds. 
Via InvestorPlace
Futures, Yields, Oil And Gold Slide As German Confidence Plummets To 2011 Lows, Euro Hits Parity
US index futures, global markets, Treasury yields, bitcoin and oil all fell on Tuesday as the dollar continued its relentless ascent to levels just shy of the March 2020 global crash record high... 
Via Talk Markets
This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market
Gainers Versus Systems Inc. (NASDAQ: VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency. 
Via Benzinga
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
Shares of DNA stock are in focus following Ark Invest's buying spree this month. In the past two days, Ark has purchased 4.5 million shares. 
Via InvestorPlace
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
DNA stock is a falling knife in 2022, and the latest earnings do not justify being optimistic about reaching profitability soon. 
Via InvestorPlace
Why Ginkgo Bioworks Stock Is Falling After Hours
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company 
Via Benzinga
7 Best Biotech Stocks to Buy in July 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. 
Via InvestorPlace
Billionaire Andreas Halvorsen Just Bought DNA Stock. Here’s Why.
DNA stock is surging higher today following large purchases from Viking Global's Andreas Halvorsen and Ark Invest's Cathie Wood. 
Via InvestorPlace
Beware These 7 Penny Stock Bubbles Getting Ready to Burst
The following penny stocks have built up a large bubble that is yet to burst. They are likely to burst soon due to the market decline. 
Via InvestorPlace
Is TSLA Stock Still a Buy? 5 Analysts Weigh In.
Tesla (TSLA) stock is a hot topic on Tuesday as analysts react to the company's EV deliveries for the second quarter of 2022. 
Via InvestorPlace
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result. 
Via InvestorPlace
Cathie Wood Is Making a Big Bet on Gingko Bioworks (DNA) Stock
Cathie Wood's Ark Invest has purchased more than 3.5 million shares of DNA stock since June 29, its first purchases in over a month. 
Via InvestorPlace
Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity... 
Via Benzinga
Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership 
Via Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves? 
Via InvestorPlace
74 Biggest Movers From Yesterday
Gainers 
Via Benzinga
ADSK Stock Sinks 8% Following Analyst Downgrade
Autodesk (ADSK) stock is slipping on Monday after getting hit with a downgrade and price target drop from Deutsche Bank analyst Bhavin Shah. 
Via InvestorPlace
Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood
Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro. 
Via Benzinga
Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock
Ark Investment Management, led by Tesla Inc. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
While Ginkgo Bioworks Holdings Inc’s (NYSE: DNA) overall first-quarter results were better than expected, revenues and active programs in its core Foundry segment fell short of estimates, according to... 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday. 
Via Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 9.65% since its last report. The company recently reported that it has 81.30 million shares sold short,... 
Via Benzinga
7 Growth Stocks to Buy on the Dip
Although the wave of red ink in the major indices is intimidating, it also presents an intriguing opportunity for growth stocks to buy. 
Via InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
DNA stock is in the spotlight after Ark Invest reported purchasing more than 1.5 million shares this week. So, who else is betting big on Ginkgo? 
Via InvestorPlace
7 Biggest Loser Stocks That Could Become Surprising Buys
A huge pouring of red ink can sometimes lead to extraordinary gains, though you’ve got to be aware of the risks. 
Via InvestorPlace
28 Biggest Movers From Yesterday
Gainers HighPeak Energy, Inc. (NASDAQ: HPK) shares gained 31.76% to close at $28.83 on Wednesday, after CNBC’s Jim Cramer said the mid-cap company is an aggressive play on... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.